301 related articles for article (PubMed ID: 11921625)
1. Rheumatology. 3. Modern drug therapies and current guidelines in rheumatology nursing.
Hill J; Reay N
Nurs Times; 2002 Mar 7-13; 98(10):41-4. PubMed ID: 11921625
[No Abstract] [Full Text] [Related]
2. The new British Society for Rheumatology disease modifying anti-rheumatic drugs guidelines.
Deighton C; Gadsby K
Musculoskeletal Care; 2006 Sep; 4(3):174-81. PubMed ID: 17042028
[No Abstract] [Full Text] [Related]
3. Standardizing assessment of adverse effects in rheumatology clinical trials. Status of OMERACT Toxicity Working Group March 2000: towards a common understanding of comparative toxicity/safety profiles for antirheumatic therapies.
Woodworth TG; Furst DE; Strand V; Kempeni J; Fenner H; Lau CS; Miller F; Day R; Lipani J; Brooks P
J Rheumatol; 2001 May; 28(5):1163-9. PubMed ID: 11361207
[TBL] [Abstract][Full Text] [Related]
4. [News in rheumatology. The Danish Society of Rheumatology].
Østergaard M; Steengaard-Pedersen K; Herlin T; Kjaer M; Døhn UM; Nørregaard J; Madsen OR;
Ugeskr Laeger; 2007 Mar; 169(12):1131. PubMed ID: 17394842
[No Abstract] [Full Text] [Related]
5. H1N1 virus and vaccination among rheumatology patients, especially those on DMARDS.
O'Connor MB; Rathi J; Bond U; Swan J; Phelan M
Ir Med J; 2010 Apr; 103(4):126-7. PubMed ID: 20491149
[No Abstract] [Full Text] [Related]
6. Herbal medications commonly used in the practice of rheumatology: mechanisms of action, efficacy, and side effects.
Setty AR; Sigal LH
Semin Arthritis Rheum; 2005 Jun; 34(6):773-84. PubMed ID: 15942912
[TBL] [Abstract][Full Text] [Related]
7. [Evidence based medicine in rheumatology].
Gause A; Raspe HH
Z Rheumatol; 2002 Oct; 61(5):516-8. PubMed ID: 12399877
[No Abstract] [Full Text] [Related]
8. MonitorNet: the Italian multi-centre observational study aimed at estimating the risk/benefit profile of biologic agents in real-world rheumatology practice.
Sfriso P; Salaffi F; Montecucco CM; Bombardieri S; Todesco S
Reumatismo; 2009; 61(2):132-9. PubMed ID: 19633800
[TBL] [Abstract][Full Text] [Related]
9. Patient based methods for assessing adverse events in clinical trials in rheumatology. Progress report for the OMERACT Drug Toxicity Working Party. Outcome Measures in Rheumatology.
Gazarian M; Tugwell P; Boers M; Bombardier C; Brooks P; Day R; Strand V; Wells G
J Rheumatol; 1999 Jan; 26(1):207-9. PubMed ID: 9918265
[TBL] [Abstract][Full Text] [Related]
10. How and when to use DMARDs.
Simmons S
Nurse Pract; 2010 Aug; 35(8):12-4. PubMed ID: 20644444
[No Abstract] [Full Text] [Related]
11. [Antimalarial preparations in rheumatology: new prospects].
Nasonov EL
Ter Arkh; 1996; 68(1):67-71. PubMed ID: 8644039
[No Abstract] [Full Text] [Related]
12. Are individual patient trials (n-of-1 trials) in rheumatology worth the extra effort?
Peloso PM
J Rheumatol; 2004 Jan; 31(1):8-11. PubMed ID: 14705210
[No Abstract] [Full Text] [Related]
13. Patients' attitudes towards, and information needs in relation to, nurse prescribing in rheumatology.
Berry D; Bradlow A; Courtenay M
J Clin Nurs; 2008 Jan; 17(2):266-73. PubMed ID: 18171396
[TBL] [Abstract][Full Text] [Related]
14. Rheumatologic rehabilitation: the great expectation for rheumatic patients.
Maddali Bongi S; Matucci Cerinic M
Reumatismo; 2012 Mar; 64(1):1-6. PubMed ID: 22472777
[No Abstract] [Full Text] [Related]
15. The history of the use of sulphasalazine in rheumatology.
Amos RS
Br J Rheumatol; 1995 Nov; 34 Suppl 2():2-6. PubMed ID: 8535643
[TBL] [Abstract][Full Text] [Related]
16. 'Life cycle in modern rheumatology' matters: new drugs require new therapeutic strategies and innovative diagnostics.
Dörner T; Burmester GR
Curr Opin Rheumatol; 2008 May; 20(3):237-8. PubMed ID: 18388511
[No Abstract] [Full Text] [Related]
17. [Therapeutic strategies: Ways to remission].
Krüger K; Edelmann E
Z Rheumatol; 2015 Jun; 74(5):386-7. PubMed ID: 26085071
[No Abstract] [Full Text] [Related]
18. Advances in targeted therapies XII. Preface.
Breedveld FC; Kalden JR; Smolen JS
Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i1. PubMed ID: 21339210
[No Abstract] [Full Text] [Related]
19. Disease-modifying antirheumatic drugs.
Belavic J
Nursing; 2010 Nov; 40(11):20. PubMed ID: 20975424
[No Abstract] [Full Text] [Related]
20. [Sulphasalazine: a promising drug in rheumatology].
Nasonov EL
Klin Med (Mosk); 1997; 75(6):39-44. PubMed ID: 9273399
[No Abstract] [Full Text] [Related]
[Next] [New Search]
